Skip to main content
. 2012 Sep 5;7(9):e44732. doi: 10.1371/journal.pone.0044732

Table 5. Determinants of abnormal ABI (ABI <0.9 or ≥1.3) in study patients.

Parameter Univariate Multivariate (Forward)
OR (95% CI) P OR (95% CI) P
Age (per 1 year) 1.033 (1.016–1.050) <0.001 - -
Male versus female 1.220 (0.822–1.812) 0.324 - -
Smoking (ever versus never) 1.199 (0.579–2.482) 0.625 - -
Diabetes mellitus 2.517 (1.701–3.723) <0.001 - -
Hypertension 2.179 (1.246–3.812) 0.006 - -
Coronary artery disease 2.175 (1.387–3.412) 0.001 5.854 (1.635–20.953) 0.007
Cerebrovascular disease 2.232 (1.272–3.917) 0.005 - -
Systolic blood pressure (per 1 mmHg) 1.001 (0.992–1.010) 0.795 - -
Diastolic blood pressure (per 1 mmHg) 0.975 (0.960–0.991) 0.003 - -
Pulse pressure (per 1 mmHg) 1.018 (1.006–1.031) 0.004 - -
Body mass index (per 1 kg/m2) 0.996 (0.950–1.045) 0.877 - -
Laboratory parameters
Albumin (per 1 g/dL) 0.527 (0.310–0.896) 0.018 - -
Fasting glucose (per 1 mg/dL) 1.007 (1.003–1.012) 0.001 1.010 (1.001–1.019) 0.026
Triglyceride (log per 1 mg/dL) 0.782 (0.320–1.909) 0.589 - -
Total cholesterol (per 1 mg/dL) 1.000 (0.995–1.005) 0.919 - -
Hematocrit (per 1%) 0.926 (0.895–0.957) <0.001 0.916 (0.855–0.980) 0.011
eGFR (per 1 mL/min/1.73 m2) 0.975 (0.964–0.986) <0.001 - -
Uric acid (per 1 mg/dL) 1.078 (0.976–1.191) 0.139 - -
Proteinuria 2.606 (1.162–5.845) 0.020 - -
Medications
Aspirin use 1.178 (0.399–3.484) 0.766 - -
ACEI and/or ARB use 1.109 (0.727–1.694) 0.631 - -
Non-ACEI/ARB antihypertensive drug use 1.593 (0.991–2.560) 0.055 - -
Statin use 1.002 (0.599–1.677) 0.993 - -
Echocardiographic data
LVMI (per 1 g/m2) 1.009 (1.005–1.013) <0.001 1.017 (1.002–1.033) 0.031
LVEF (per 1%) 0.990 (0.977–1.003) 0.126 - -
E-wave deceleration time (per 1 ms) 1.002 (0.999–1.005) 0.196 - -
E/A (per 1) 1.045 (0.730–1.496) 0.810 - -

Values expressed as odds ratio (OR) and 95% confidence interval (CI). Abbreviations are the same as in Table 1.